Showing 141 - 160 results of 194 for search '"DJ"', query time: 0.05s Refine Results
  1. 141

    Dysregulation of Metabolic Peptides Precedes Hyperinsulinemia and Inflammation Following Exposure to Rotenone in Rats by Vandana Zaman, Denise Matzelle, Naren L. Banik, Azizul Haque

    Published 2025-01-01
    “…It is a classical, high-affinity mitochondrial complex I inhibitor that causes not only oxidative stress, α-synuclein phosphorylation, DJ-1 (Parkinson’s disease protein 7) modifications, and inhibition of the ubiquitin-proteasome system but it is also widely considered an environmental contributor to Parkinson’s disease (PD). …”
    Get full text
    Article
  2. 142

    A Framework for Coxeter Spectral Classification of Finite Posets and Their Mesh Geometries of Roots by Daniel Simson, Katarzyna Zając

    Published 2013-01-01
    “…In case GJ is positive semi-definite of corank one, we relate the Coxeter spectral properties of the posets J with the Coxeter spectral properties of a simply laced Euclidean diagram DJ∈{𝔻̃n,𝔼̃6,𝔼̃7,𝔼̃8} associated with J. Our aim of the Coxeter spectral analysis of such posets J is to answer the question when the Coxeter type CtypeJ:=(speccJ,cJ,  čJ) of J determines its incidence matrix CJ (and, hence, the poset J) uniquely, up to a ℤ-congruency. …”
    Get full text
    Article
  3. 143
  4. 144
  5. 145
  6. 146
  7. 147
  8. 148
  9. 149
  10. 150
  11. 151

    Genetinių tyrimų svarba Parkinsono ligos diagnostikoje by Dominika Dakinevičiūtė, Jolita Čičelienė

    Published 2024-11-01
    “…Dažniausiai literatūroje išskiriami SNCA, VPS35, PRKN, LRRK2, PINK1 ir DJ1 genai. Genų penetrantiškumas yra skirtingas, gali būti mažas arba didelis, atsižvelgiant į tai galima interpretuoti ligos pasireiškimo tikimybę. …”
    Get full text
    Article
  12. 152

    Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson’s Disease: A Meta-Analysis by Dan Xie, Ling Feng, Hongyan Huang, Quanzhen Zhao, Pingping Ning, Qiuyan Shen, Haitao Lu, Fang Xu, Yanming Xu

    Published 2021-01-01
    “…MSA patients had higher CSF t-tau (SMD=0.41, 95% CI: 0.10 to 0.72) and YKL-40 (SMD=0.63, 95% CI 0.12 to1.15) as well as DJ-1 (SMD=1.05, 95% CI 0.67 to 1.42) levels than PD patients, while CSF p-tau (SMD=−0.17, 95% CI, -0.31 to -0.02) and Aβ-42 (SMD=−0.33, 95% CI, -0.55 to -0.12) levels in MSA patients were lower than those in PD patients. …”
    Get full text
    Article
  13. 153
  14. 154
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160